UHS executives said there was an “unfavorable after-tax impact” of $16.8 million, which included an $18.1 million after-tax charge that resulted from the write-off of deferred financing costs from its term loan B credit facility. UHS lowered its profit outlook for the rest of the year due to the results as well as “the backdrop of a continued sluggish economic recovery.”
Overall, UHS’ net revenue in the third quarter increased a mild 1 percent, from $1.66 billion in 2011 to $1.68 billion. EBITDA rose 2.5 percent to $265.4 million in the third quarter, as well.
In the nine months ended Sept. 30, 2012, UHS posted net income of $308 million, a 1.7 percent increase from the first nine months of 2011. Net revenue ticked upward by 1.9 percent to $5.2 billion.
Same-facility admissions in UHS’ acute-care hospitals dropped 2.6 percent in the third quarter, while the length of stay increased 0.7 percent. Currently, UHS operates 25 acute-care hospitals and 175 behavioral health facilities.
More Articles on Universal Health Services:
For-Profit Hospital Stock Report: Week of Oct. 22-26, 2012
Universal Health Services Completes Divestiture of Auburn Regional Medical Center
Moody’s: Universal Health Services’ Acquisition Strategy May Limit Debt Repayment
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
